Related Experiment Video
Updated: Aug 12, 2026

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
Cholesterol, coronary heart disease and stroke: a review of published evidence from observational studies and
Rachel Huxley1, Sarah Lewington, Robert Clarke
1Department of Public Health Sciences, University of Oxford, Oxford, England.
Insights
Lowering blood cholesterol, particularly LDL cholesterol, significantly reduces coronary heart disease (CHD) risk. This benefit is continuous, with no safe lower threshold, and is more pronounced in individuals with higher overall cardiovascular risk.
Area of Science:
- Cardiovascular Epidemiology
- Nutritional Science
- Clinical Trials
Background:
- Observational studies show a continuous inverse relationship between blood cholesterol and coronary heart disease (CHD) risk across normal ranges.
- A 1 mmol/l difference in total cholesterol is linked to a one-third reduction in middle-aged CHD mortality.
- No cholesterol threshold exists below which lower levels do not reduce risk.
Purpose of the Study:
- To analyze the relationship between blood cholesterol levels and CHD risk.
- To evaluate the effectiveness and safety of cholesterol-lowering interventions.
- To identify factors influencing the benefits of cholesterol reduction.
Main Methods:
- Analysis of observational epidemiologic studies on cholesterol and CHD risk.
- Review of large-scale cholesterol-lowering clinical trials in high-risk patients.
- Examination of the composition of blood cholesterol (LDL and HDL) and its impact on vascular risk.
Main Results:
- Lowering LDL cholesterol by 1 mmol/l may reduce CHD risk by 40-50%.
- Cholesterol-lowering trials confirm epidemiologically predicted risk reductions without increasing non-CHD mortality.
- Benefits of LDL cholesterol reduction are greater in individuals with higher absolute CHD risk.
Conclusions:
- Dietary saturated fat is a primary driver of total and LDL cholesterol levels.
- Dietary modifications, such as replacing saturated fats, can significantly lower cholesterol.
- Targeting LDL cholesterol reduction is crucial for managing cardiovascular risk, especially in high-risk populations.
Abstract:
In observational epidemiologic studies, lower blood cholesterol is associated with a reduced risk from coronary heart disease (CHD) throughout the normal range of cholesterol values observed in most Western populations. There is a continuous positive relationship between CHD risk and blood cholesterol down to at least 3 to 4 mmol/l, with no threshold below which a lower cholesterol is not associated with a lower risk. Observational studies suggest that a prolonged difference in total cholesterol of about 1 mmol/l is associated with one-third less CHD deaths in middle age. Evidence from large-scale cholesterol lowering trials in patients at high-risk of CHD have demonstrated that much of the epidemiologically predicted difference in CHD risk associated with differences in cholesterol was achieved within a few years of treatment. Moreover, these trials have demonstrated that such therapy was not associated with increased non-CHD mortality. Total cholesterol is transported in blood as low-density lipoprotein cholesterol or LDL cholesterol (about 70%) and as high density lipoprotein cholesterol or HDL cholesterol (about 30%). Since these two cholesterol fractions have opposing effects on vascular risk, a 1 mmol/l reduction in LDL cholesterol is likely to be associated with 40 to 50% lower CHD risk. The size of the absolute reduction in CHD produced by lowering total and LDL cholesterol is determined by an individual's overall risk rather than their initial cholesterol level. Consequently, the benefits of drug treatment to lower LDL cholesterol are greater in those at higher absolute risk of CHD rather than at high cholesterol levels. Dietary saturated fat is the chief determinant of total and LDL cholesterol levels. Replacing 60% of the intake of saturated fat by other fats and reducing the intake of dietary cholesterol could reduce blood total cholesterol levels by about 0.8 mmol/l (that is by 10 to 15%), with four fifths of this reduction being in LDL cholesterol.
More Related Videos
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management

